Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Calidi Biotherapeutics, Inc.

NYSE: CLDI · Life Sciences · 4 alerts · CIK 1855485

Share price
$0.6023Close, Nov 16
Market cap
$2.08M
Shares outstanding
3.45MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Calidi Biotherapeutics, Inc. filings on SEC EDGAR ↗

5:01 PM ET 10-Q
Financial Results

Calidi Biotherapeutics Q3 2026 Results: Net Loss of $3.65M, Loss Narrows

Calidi Biotherapeutics reported a net loss of $11.9 million for the nine months ended September 30, 2026, compared to a $16.0 million loss in the prior year period. The company maintained a cash balance of $3.9 million as of September 30, 2026, and completed a 1-for-16 reverse stock split in July 2026 to adjust its capital structure.

Key figure
Net loss $3.65M
4:35 PM ET 8-K
Financial Results

Calidi Biotherapeutics Financial Results

Calidi Biotherapeutics reported a net loss of $3.6 million for the third quarter of 2026, a significant improvement from the $10.8 million loss in the prior year period. The company highlighted preclinical progress for its CLD-401 program and implemented a restructuring plan on November 6, 2026, to reduce headcount and save $3 million annually. During the quarter, the company also raised $1.2 million through an at-the-market offering to extend its cash runway.

Term
Q3 2026

“Throughout the third quarter, Calidi continued to advance its RedTail platform for systemic and local delivery and redefine the potential of oncolytic viruses and genetic medicine. In particular, CLD-401 demonstrated remarkable anti-tumor activity with systemic administration in syngeneic tumor models and continues to progress towards the clinic.”

Eric Poma, Ph.D., Calidi Biotherapeutics CEO

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.